Comparison of Oral Absorption and Bioavailability of Drugs Between Monkey and Human

AbstractPurpose. To compare the oral absorption and bioavailability of numerous drugs with a wide variety of physicochemical and pharmacological properties between humans and monkeys and to explore potential reasons for the findings. Methods. Data for fraction of dose absorbed (Fa) and oral absolute bioavailability (F) were obtained by an extensive Medline database search. Inclusion and exclusion criteria were the same as those reported in our previous studies. A total of 43 and 35 drugs were selected for Fa and F comparison, respectively. The time to reach peak concentration (tmax), total clearance, and nonrenal clearance were evaluated for 15, 28, and 13 drugs, respectively. Results. Fa values in monkeys were similar or identical to those in humans. Additionally, similar tmax values were seen in monkeys and humans at comparable doses, thus indicating comparable absorption kinetics between the two species. Conversely, F values in monkeys were generally lower with coumarin being a marked exception. Both total and nonrenal clearances were evaluated and found to be generally greater in monkeys, supporting a generally higher first-pass metabolism and lower F in this species. This was also supported by published data suggesting greater in vitro hepatic drug metabolism for monkeys as compared to humans. Conclusions. Monkeys appear to be a good predictor of Fa in humans. However, a generally lower F makes monkeys a potentially poor predictor of human F. Higher reported metabolic clearances and hepatic enzyme activities in monkeys may account for this observation.

[1]  W. L. Chiou,et al.  The Rate and Extent of Oral Bioavailability versus the Rate and Extent of Oral Absorption: Clarification and Recommendation of Terminology , 2001, Journal of Pharmacokinetics and Pharmacodynamics.

[2]  W. L. Chiou,et al.  Similarity in the linear and non-linear oral absorption of drugs between human and rat. , 2000, International journal of clinical pharmacology and therapeutics.

[3]  W. L. Chiou.  New perspectives on the theory of permeability and resistance in the study of drug transport and absorption , 1996, Journal of Pharmacokinetics and Biopharmaceutics.

[4]  A. Barve,et al.  Linear Correlation of the Fraction of Oral Dose Absorbed of 64 Drugs Between Humans and Rats , 1998, Pharmaceutical Research.

[5]  H. Yamazaki,et al.  Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans , 1997, Archives of Toxicology.

[6]  S. R. Howell,et al.  Pharmacokinetics of venlafaxine and O-desmethylvenlafaxine in laboratory animals. , 1994, Xenobiotica; the fate of foreign compounds in biological systems.

[7]  W. L. Chiou.  We may not measure the correct intestinal wall permeability coefficient of drugs: Alternative absorptive clearance concept , 1995, Journal of Pharmacokinetics and Biopharmaceutics.

[8]  T. Kararli.  Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals , 1995, Biopharmaceutics & drug disposition.

[9]  D A Smith,et al.  Pharmacokinetics and toxicity testing. , 1984, Critical reviews in toxicology.

[10]  J. Lin,et al.  Comparative in vitro metabolism of indinavir in primates - a unique stereoselective hydroxylation in monkey , 2000, Xenobiotica; the fate of foreign compounds in biological systems.

[11]  S K Balani,et al.  Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[12]  M. Hayashi,et al.  Species differences in oral bioavailability of methotrexate between rats and monkeys. , 2000, Biological & pharmaceutical bulletin.

[13]  W. Krause,et al.  Pharmacokinetics of rolipram in the rhesus and cynomolgus monkeys, the rat and the rabbit. Studies on species differences. , 1988, Xenobiotica; the fate of foreign compounds in biological systems.

[14]  S. R. Howell,et al.  Metabolic disposition of 14C-venlafaxine in mouse, rat, dog, rhesus monkey and man. , 1993, Xenobiotica; the fate of foreign compounds in biological systems.

[15]  W. Ritschel,et al.  Pharmacokinetics of coumarin and 7-hydroxycoumarin in the rhesus monkey after intravenous and peroral administration. , 1988, Arzneimittel-Forschung.

[16]  P L Morselli,et al.  Comparative pharmacokinetic profile of two imidazopyridine drugs: zolpidem and alpidem. , 1992, Drug metabolism reviews.

[17]  G. Hoyer,et al.  Biotransformation of the antidepressant DL-rolipram. I. Isolation and identification of metabolites from rat, monkey, and human urine. , 1993, Drug metabolism and disposition: the biological fate of chemicals.

[18]  J. Lin,et al.  Species similarities and differences in pharmacokinetics. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[19]  Xiaochun Lou,et al.  Allometric Pharmacokinetic Scaling: Towards the Prediction of Human Oral Pharmacokinetics , 2000, Pharmaceutical Research.

[20]  C. Bonfils,et al.  Oxidative metabolism of zolpidem by human liver cytochrome P450S. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[21]  Hyunyoung Jeong,et al.  Evaluation of Using Dog as an Animal Model to Study the Fraction of Oral Dose Absorbed of 43 Drugs in Humans , 2000, Pharmaceutical Research.

[22]  W. Krause,et al.  Biotransformation of the antidepressant D,L-rolipram. II. Metabolite patterns in man, rat, rabbit, rhesus and cynomolgus monkey. , 1993, Xenobiotica; the fate of foreign compounds in biological systems.

[23]  S. Binkley,et al.  Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[24]  Sietsema Wk,et al.  The absolute oral bioavailability of selected drugs , 1989 .

[25]  S. Wrighton,et al.  Comparison of human and rhesus monkey in vitro phase I and phase II hepatic drug metabolism activities. , 1993, Drug metabolism and disposition: the biological fate of chemicals.